{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:56:19Z","timestamp":1787007379837,"version":"build-2736575974"},"reference-count":74,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,5,4]]},"DOI":"10.1080\/14740338.2023.2218086","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:16:42Z","timestamp":1684923402000},"page":"355-362","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":37,"title":["Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-7391","authenticated-orcid":false,"given":"Angelo","family":"Ruggiero","sequence":"first","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-0592","authenticated-orcid":false,"given":"Luca","family":"Potestio","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Martora","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Villani","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"Comune","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-2046","authenticated-orcid":false,"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051031"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.18.06202-8"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.01.014"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2036674"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15524"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2160447"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2081655"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15214"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2013.853739"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093233"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00184-7"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15667"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01612-z"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2173170"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2113092"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00125-2"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102383"},{"key":"e_1_3_5_22_1","unstructured":"Clinical trial from clinicaldatabase.gov. A study to evaluate the efficacy and safety of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis (BE BRIGHT). Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03598790?term=BE+BRIGHT&draw=2&rank=1. Accessed Mar 13 2023."},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00126-4"},{"key":"e_1_3_5_24_1","unstructured":"Bimekizumab (BIMZELX). Summary of product characteristic - drug insert package. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bimzelx-epar-product-information_en.pdf (last access Mar 8 2023)."},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01894"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13185"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20827"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S267405"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.037"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.05.105"},{"key":"e_1_3_5_31_1","doi-asserted-by":"crossref","unstructured":"Strober B Paul C Blauvelt A et al. Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial. J Am Acad Dermatol. 2023;S0190\u20139622(23)00782-X.","DOI":"10.1016\/j.jaad.2023.04.063"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00883-y"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac021"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18341"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15286"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S364640"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00556-2"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2173171"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S402183"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15952"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15543"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346\u20138138.16707"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20153038"},{"issue":"4","key":"e_1_3_5_44_1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4103\/ijd.ijd_572_22","article-title":"Impact of Psoriasis on quality of life","volume":"67","author":"Agarwal K","year":"2022","unstructured":"Agarwal K, Das A, Das S, et al. Impact of Psoriasis on quality of life. Indian J Dermatol. 2022;67(4):387\u2013391.","journal-title":"Indian J Dermatol"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15120"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2113872"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15030"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212127"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01894"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S367744"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2134855"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15102"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.1185"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00340-3"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15723"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101482"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.025"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14808"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14245"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109853"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3816"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15374"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15941"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00795-x"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15336"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061511"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2089020"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14528"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1882-2"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.024"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15809"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15395"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14938"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac133"},{"issue":"3","key":"e_1_3_5_76_1","first-page":"311","article-title":"Anti-IL-17 agents for Psoriasis: a review of phase III data","volume":"15","author":"Farahnik B","year":"2016","unstructured":"Farahnik B, Beroukhim K, Nakamura M, et al. Anti-IL-17 agents for Psoriasis: a review of phase III data. J Drugs Dermatol. 2016;15(3):311\u2013316.","journal-title":"J Drugs Dermatol"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2218086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T20:53:42Z","timestamp":1729457622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2218086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,4]]}},"alternative-id":["10.1080\/14740338.2023.2218086"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2218086","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}